Jiang Longwei

Jiangsu Longwei Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and advanced intermediates. The company is particularly recognized for its expertise in central nervous system (CNS) therapeutics, producing high-quality generic APIs such as Gabapentin, Pregabalin, and Levetiracetam. Operating out of its manufacturing base in Jiangsu, the company serves as a key contract manufacturing partner for global pharmaceutical firms, providing GMP-compliant production services. Its business model focuses on the synthesis of complex small molecules and the optimization of chemical processes for commercial-scale supply.